Zenas BioPharma Grants 51,075 RSUs to New Hires, Vesting 2027–2030
Zenas BioPharma granted 51,075 restricted stock units to newly hired employees on May 15, 2026 under Nasdaq Listing Rule 5635(c)(4) as inducement awards. The RSUs vest in four equal annual installments on May 15 of each year from 2027 through 2030, subject to continued service under the 2026 Inducement Plan.
1. Inducement Grant Awarded
On May 15, 2026, Zenas BioPharma’s Compensation Committee granted an aggregate of 51,075 restricted stock units to newly hired employees as an inducement material to their entry into employment under Nasdaq Listing Rule 5635(c)(4).
2. Vesting and Service Conditions
The RSUs vest in four equal installments of 25% each on May 15 of 2027, 2028, 2029 and 2030, contingent on the employees’ continued service through each vesting date.
3. Inducement Plan Framework
The awards are governed by the company’s 2026 Inducement Plan and individual award agreements, outlining the terms, conditions and forfeiture provisions applicable to the RSUs.